Danaher Co. (NYSE:DHR – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty brokerages that are currently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $285.55.
A number of research analysts have weighed in on the company. Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Stifel Nicolaus raised their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research note on Thursday, October 31st. TD Cowen raised their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd.
Read Our Latest Stock Analysis on Danaher
Danaher Stock Up 0.1 %
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.
Hedge Funds Weigh In On Danaher
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter valued at $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher in the 3rd quarter valued at $39,000. MidAtlantic Capital Management Inc. acquired a new position in Danaher in the 3rd quarter valued at $40,000. Finally, FSA Wealth Management LLC acquired a new position in Danaher in the 3rd quarter valued at $50,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What is a Secondary Public Offering? What Investors Need to Know
- Bloom Energy: Powering the Future With Decentralized Energy
- Why is the Ex-Dividend Date Significant to Investors?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Investing in Construction Stocks
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.